PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 234 filers reported holding PDL BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $92,000 | +15.0% | 11,990 | +11.6% | 0.01% | 0.0% |
| Q3 2014 | $80,000 | -21.6% | 10,739 | +1.8% | 0.01% | -23.1% |
| Q2 2014 | $102,000 | -72.0% | 10,550 | -75.9% | 0.01% | -74.5% |
| Q1 2014 | $364,000 | -50.5% | 43,766 | -49.9% | 0.05% | -8.9% |
| Q4 2013 | $736,000 | +143.7% | 87,302 | +130.5% | 0.06% | +5.7% |
| Q3 2013 | $302,000 | +6.3% | 37,878 | +2.8% | 0.05% | -5.4% |
| Q2 2013 | $284,000 | – | 36,830 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |